SPH sales revenues for february 2021

Sopharma AD notifies that for February 2021 the Company recorded a decrease in sales of 1% compared to the same month of 2020, incl. 34% increase in domestic sales and 12% decrease in export sales.
In the first two months of 2021 the revenues from sales of production increase by 4% compared to the same period of 2020, incl. 27% increase of sales for the domestic market and 4% decrease in export sales.